2Weber MA, Byyny RL, Pratt JH, et al. Blood pressure effects of the angiotensin Ⅱ receptor blood, Losartan. Arch Intern Med, 1995,155:205.
3Chalmers J, Pilowsky P. Brain stem and bulbo spinal neurotransmitrer systems in the control of blood pressure. J Hypertens, 1996,9:675.
4Dunn FG, Hillis WS, Tweddel, et al. Noninvasive cardiovascular assessment of indapamede in patients with essential hypertension. Postgrad Med J, 1981,21:19.
5Chobanian AV, Bakris C,L, Black HR,et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treat- ment of high blood pressure: the JNC 7 report [J]. JAMA, 2003 ; 289 (19) :2560-72.
6London GM. Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure [ J]. J Hum Hypertens ,2004 ; 18 ( Suppl 2) :S9-S14.
7Puig JG, Marre M, Kokot F, et al. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes [J]. Am J Hypertens ,2007 ;20( 1 ) :90-7.
8Akram J, Sheikh UE, Mahmood M, et al. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy : the NATIVE study [ J]. Curr Meal Res Opin, 2007 ; 23 ( 12 ) : 2929-36.
9[1]Arrowsmith JE, Campbell SF, Cross PE et al.Long-Acting dihydropyridinc calcium antagnoists 1, 2-Alkoxymethyl derivatives incorporating basic substituents [J]. J Med Chem, 1986 ; 29 : 1696-1702
10[2]Bnurges R, Moisey D. Unique pharmacologic properties of amlodipine [J]. Am J Cardiol, 1994 ; 73 : 2A-9A
